Combination approach to diagnosis and treatment of an elderly patient with chronic Ph-negative myeloproliferative neoplasm and concomitant surgical pathology. Clinical observation
- Authors: Ryabukhina Y.E.1, Zeynalova P.A.1, Timofeeva O.I.1, Abbasbeyli F.M.1, Ponomarev T.V.1, Kupryshina N.A.2, Zhukov A.G.1
-
Affiliations:
- Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
- N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
- Issue: Vol 1, No 1 (2021)
- Pages: 61-65
- Section: RARE NEOPLASMS AND COMPLEX CLINICAL SITUATIONS: DIFFICULTIES IN DIAGNOSIS AND SELECTION OF TREATMENT TACTICS
- Published: 06.12.2021
- URL: https://mdonco.abvpress.ru/jour/article/view/12
- DOI: https://doi.org/10.17650/2782-3202-2021-1-1-61-65
- ID: 12
Cite item
Full Text
Abstract
Chronic myeloproliferative neoplasms (CMPN), Ph-negative, are of clonal nature, develop on the level of hematopoietic stem cell and are characterized by proliferation of one or more hematopoietic pathways. Currently, the group of Ph-negative CMPN includes essential thrombocythemia, primary myelofibrosis, polycythemia vera, myeloproliferative neoplasm unclassifiable.
Identification of mutations in the Jak2 (V617F), CALR, and MPL genes extended understanding of biological features of Ph-negative CMPN and improved differential diagnosis of myeloid neoplasms. Nonetheless, clinical practice still encounters difficulties in clear separation between such disorders as primary myelofibrosis, early-stage and transformation of essential thrombocythemia into myelofibrosis with high thrombocytosis.
Thrombocytosis is one of the main risk factors for thromboembolic complications, especially in elderly people.
A clinical case of an elderly patient with fracture of the left femur developed in the context of Ph-negative CMPN (myelofibrosis) with high level of thrombocytosis is presented which in combination with enforced long-term immobilization and presence of additional risk created danger of thrombosis and hemorrhage during surgery and in the postoperative period.
About the authors
Yu. E. Ryabukhina
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
Author for correspondence.
Email: gemonk.yur@mail.ru
ORCID iD: 0000-0001-8443-8816
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081, Russia
Russian FederationP. A. Zeynalova
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
ORCID iD: 0000-0003-1564-424X
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081, Russia
Russian FederationO. I. Timofeeva
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
ORCID iD: 0000-0002-6229-7300
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081, Russia
Russian FederationF. M. Abbasbeyli
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
ORCID iD: 0000-0002-2359-0547
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081, Russia
Russian FederationT. V. Ponomarev
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081, Russia
Russian FederationN. A. Kupryshina
N.N. Blokhin National Medical Research Center of Oncology, Ministry of Health of Russia
ORCID iD: 0000-0001-8509-0954
24 Kashirskoe Shosse, Moscow 115478, Russia
Russian FederationA. G. Zhukov
Clinical Hospital “Lapino” of the “Mother and Child” Group of companies
111 1st Uspenskoe Shosse, Lapino, Moscow region 143081, Russia
Russian FederationReferences
- Melikyan A.L., Kovrigina A.M., Zubareva I.N. et al. National clinical guidelines for the diagnosis and treatment of Ph-negative myeloproliferative diseases (true polycythemia, essential thrombocytemia, primary myelofibrosis) (revision 2020). Klinicheskaya onkogematologiya = Clinical Hematology 2021;14(2):262–98.(In Russ.). doi: 10.21320/2500-2139-2021-14-2-262-298.
- Melikyan A.L., Subocheva I.N. Biology of myeloproliferative neoplasms. Klinicheskaya onkogematologiya = Clinical Oncohematology 2016;9(3):314–25. (In Russ.). doi: 10.21320/2500-2139-2016-9-3-314-325.
- Mughal T.I., Vaddi K., Sarris N. et al. Myelofibrosis-associated complications: pathogenesis, clinical manifestations and effects on outcomes. Int J Gen Med 2014;7:89–101. doi: 10.2147/IJGM.S51800.
- Dulaev A.K., Potapchuk A.A., Tsed A.N. Features of surgical treatment and rehabilitation of elderly patients with transversal femoral fractures. Ucheniye zapisky SPbGMU im. akad. I.P. Pavlova = Scientific Notes of St. Petersburg State Medical University n. a. Academician I.P. Pavlov 2011;18(3):40–3. (In Russ.).
- Harrington P., Nihal A., Howell F.R. Intramedullary hip screw versus sliding hip screw for unstable intertrochanteric femoral fractures in the elderly. Injury 2002;33(1):23–8. doi: 10.1016/s0020-1383(01)00106-1.
Supplementary files

